Back
INmune Bio Vs. Theriva Biologics Industry Stock Comparison
Sell
41
INMB
INmune Bio
Last Price:
5.84
Seasonality Move:
36.39%
Sell
20
TOVX
Theriva Biologics
Last Price:
1.44
Seasonality Move:
53.38%
Sell
41
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
- The current INmune Bio [INMB] share price is $5.95. The Score for INMB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.48. The Score for TOVX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- TOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $5.95
The current trend is relatively stagnant and INMB is experiencing slight selling pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.48
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
INMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.08 | Buy |
| Chaikin Money Flow: | -142114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.94 - 5.66) | Buy |
| Bollinger Bands (100): | (5.51 - 8.29) | Sell |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 36.46 | Sell |
| Chaikin Money Flow: | -59567 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.78) | Sell |
| Bollinger Bands (100): | (2.4 - 6.32) | Sell |
INMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.55 | Buy |
| 20-day SMA: | 5.33 | Buy |
| 50-day SMA: | 5.7 | Buy |
| 200-day SMA: | 9.08 | Sell |
| 8-day EMA: | 5.68 | Buy |
| 20-day EMA: | 5.48 | Buy |
| 50-day EMA: | 5.88 | Buy |
| 200-day EMA: | 7.88 | Sell |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.49 | Sell |
| 20-day SMA: | 1.51 | Sell |
| 50-day SMA: | 2.67 | Sell |
| 200-day SMA: | 7.54 | Sell |
| 8-day EMA: | 1.49 | Sell |
| 20-day EMA: | 1.7 | Sell |
| 50-day EMA: | 2.7 | Sell |
| 200-day EMA: | 7 | Sell |
INmune Bio Earnings Growth & INMB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and an increase next year of $0.23 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
INmune Bio Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||